Desmoglein 1 and 3 enzyme‐linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity
- 18 June 2007
- journal article
- research article
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 21 (10) , 1319-1324
Abstract
Background Pemphigus vulgaris (PV) is a chronic autoimmune blistering disorder of the skin and mucosa characterized by the presence of autoantibodies against desmoglein3 (Dsg3). Some patients also have antibodies against desmoglein1 (Dsg1). The aims of this study were to evaluate the diagnostic value of Dsg enzyme‐linked immunosorbent assay (ELISA) in Iranian PV patients, to assess its correlation with the clinical phenotype and severity of disease and to investigate the changes of these antibodies after treatment.Methods Seventy‐three patients with PV (29 men, 44 women) presenting to the Pemphigus Research Unit at Razi Hospital, Tehran, Iran were enrolled. ELISAs were used to detect IgG autoantibodies reactive with the ectodomains of Dsg1 and Dsg3, and the correlation of antibodies with the clinical phenotype as well as oral and skin disease severity was assessed. In addition, the tests were repeated in 18 patients after treatment and the resulting remission.Results Anti‐Dsg1 and anti‐Dsg3 were detected in 56 (76.7%) and 69 (94.5%) patients, respectively. Anti‐Dsg1 and anti‐Dsg3 antibodies were present in 48 (94.1%) and 50 (98%) patients with mucocutaneous type, in 2 (12.5%) and 15 (93.7%) patients with mucosal type, and in 6 (100%) and 4 (66.7%) patients with cutaneous PV, respectively. The mean anti‐Dsg1 index values were significantly higher in cutaneous and mucocutaneous phenotypes than mucosal PV (P < 0.001). The mean anti‐Dsg3 index values were significantly lower in cutaneous and mucosal phenotypes than mucocutaneous PV (P < 0.01). The severity of skin lesions (but not oral lesions) was correlated with anti‐Dsg1 antibody level (P < 0.001); on the other hand, the severity of oral lesions (P < 0.01) as well as skin lesions (P < 0.001) was significantly correlated with anti‐Dsg3 antibody levels. Both anti‐Dsg1 and anti‐Dsg3 levels were significantly reduced after treatment and clinical remission (P < 0.001).Conclusion Dsg ELISA is not only a sensitive tool for the diagnosis of PV, it can also serve as a predictive means for assessing the severity as well as for monitoring the disease activity. Although, in general, the clinical phenotype is related to the antibody profile, there are occasional cases with discordant phenotype and antibody profile. These discrepancies might be explained by genetic variations or the presence of possible minor antigens involved in the pathogenesis of pemphigus.Keywords
This publication has 30 references indexed in Scilit:
- Are desmoglein autoantibodies essential for the immunopathogenesis of pemphigus vulgaris, or just ‘witnesses of disease'?Experimental Dermatology, 2006
- Viewpoint 1Experimental Dermatology, 2006
- Evaluation of desmoglein enzyme‐linked immunosorbent assay (ELISA) in Indian patients with pemphigus vulgarisInternational Journal of Dermatology, 2006
- Significance of autoimmunity to non-desmoglein targets in pemphigusAutoimmunity, 2006
- Transition from Pemphigus Foliaceus to Pemphigus Vulgaris: Case Report with Literature ReviewYonsei Medical Journal, 2006
- Pemphigus Vulgaris with No Mucosal Lesions Showing Pemphigus-Foliaceus-Like Skin Manifestations: Is There a ‘Cutaneous Type’ of Pemphigus Vulgaris?Dermatology, 2005
- Pemphigus: Analysis of 1209 casesInternational Journal of Dermatology, 2005
- Cutaneous type pemphigus vulgaris: A rare clinical phenotype of pemphigusJournal of the American Academy of Dermatology, 2005
- Limitations in Enzyme-linked Immunosorbent Assays for Antibodies Against Desmogleins 1 and 3 in Patients With PemphigusArchives of Dermatology, 2002
- Diagnosis of pemphigus by ELISA: a critical evaluation of two ELISAs for the detection of antibodies to the major pemphigus antigens, desmoglein 1 and 3Clinical and Experimental Dermatology, 2000